News
GSK (LSE:GSK) announced that the European Medicines Agency accepted its regulatory application to expand the use of its RSV ...
Confirms Single Phase 3 Immuno-Bridging Trial Sufficient to Evaluate Efficacy and to Support a Marketing Authorization ...
Pharmaceutical Technology on MSN20h
Averoa secures EC authorisation for oral CKD treatmentThe European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney ...
Asianet Newsable on MSN4d
GSK’s Application To European Authorities For Expanded Use Of RSV Vaccine In Younger Adults Fails To Rejuvenate Retail OptimismArexvy is already approved in the European Economic Area for the prevention of lower respiratory tract disease (LRTD) caused ...
GSK has applied to the European Medicines Agency to expand use of its respiratory syncytial virus (RSV) vaccine to adults ...
The latest update atopic dermatitis guidelines include the new approval of lebrikizumab and the expanded use of baricitinib ...
The purpose of the pharma package is to revise the current rules on medicines to make them more accessible to patients while ...
A comprehensive analysis conducted by public health experts at Novartis Romania reveals that Romanian patients may wait, on ...
The Patented Medicine Prices Review Board (PMPRB) published the 9th edition of its annual Meds Entry Watch report today. Like last year, the analysis finds that the number of new medicines launched in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback